Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche
M. M. Ricetti(University of Verona), G. Perona(University of Verona), Antonella Rigo(University of Verona), G. Pizzolo, Gianpaolo Nadali(Azienda Ospedaliera Universitaria Integrata Verona), Achille Ambrosetti(International Extranodal Lymphoma Study Group), C. Vincenzi(University of Verona), Giuseppe Todeschini(University of Pisa), Mauro Krampera(University of Verona)
Unknown
January 1, 1997
Cited by 0
Related Papers
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
<i>Pneumocystis carinii</i> pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres
|British Journal of Haematology|2002|149